HKSE:02591 (China)
Â
Ordinary Shares - Class H
HK$
3.99
+0.050 (+1.27%)
Sep 11
Guangzhou Innogen Pharmaceutical Group Co Ltd Valuation Measures
Fundamental (50)
Valuation Ratio (87)
Profitability (8)
Price (22)
Dividends (7)
Income Statement (47)
Balance Sheet (85)
Cashflow statement (66)